Recently, it has been shown that vildagliptin in combination with rapamycin significantly enhanced the insulin mimetic effect of rapamycin in patients with T1DM possibly by improving postprandial glucagon secretion and insulin sensitivity. The gene discussed is INS; the disease is type 1 diabetes mellitus.